Organogenesis Holdings (ORGO) Treasury Shares (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Treasury Shares of $5.6 million for Q1 2026, up 836.7% year-over-year from $602727.0 in Q1 2025, and up 1319.24% quarter-over-quarter from $397800.0 in Q4 2025.
Organogenesis Holdings (ORGO) Treasury Shares (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Treasury Shares history runs 11 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 836.7% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (up 836.7% YoY), while the FY2025 annual figure was $397800.0, down 91.22% from the prior year.
- Treasury Shares for Q1 2026 stood at $5.6 million, up from $397800.0 in the prior quarter.
- The five-year high for Treasury Shares was $5.6 million in Q1 2026, with the low at $130000.0 in Q4 2024.
- The 5-year median for Treasury Shares is $4.0 million (2023), against an average of $3.0 million.
- The sharpest annual moves came in 2024 and 2026: Treasury Shares slumped 96.67% in 2024, then surged 836.7% in 2026.
- Organogenesis Holdings' Treasury Shares stood at $1.4 million in 2022, then soared by 182.18% to $3.9 million in 2023, then plunged by 96.67% to $130000.0 in 2024, then jumped by 206.0% to $397800.0 in 2025, then jumped by 1319.24% to $5.6 million in 2026.
- Business Quant data shows ORGO's Treasury Shares at $5.6 million in Q1 2026, $397800.0 in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 19.00 Mn |
| 10 | Organogenesis Holdings | 240.62 Mn | 193.78 Mn | 20.08 Mn | 130,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 130,000.00 |
| Jun 30, 2026 | 130,000.00 |
| Mar 31, 2026 | 5.65 Mn |
| Mar 31, 2026 | 5.65 Mn |
| Dec 31, 2025 | 397,800.00 |
| Dec 31, 2025 | 397,800.00 |
| Sep 30, 2025 | 4.77 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 4.79 Mn |
| Mar 31, 2025 | 602,727.00 |
| Mar 31, 2025 | 602,727.00 |
| Dec 31, 2024 | 130,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 4.30 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 4.33 Mn |
| Jun 30, 2024 | 4.33 Mn |
| Mar 31, 2024 | 4.27 Mn |
| Mar 31, 2024 | 4.27 Mn |